Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-08
2007-05-08
Turner, Sharon (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
10170481
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: WO 99/46281 (1999-09-01), None
Skolnick et al., Trends in Biotech., 18(1):34-39, 2000.
Jobling et al, Mol. Microbiol., 1991, 5(7):1755-67.
Hillier, L., et al., “The Washu-Merck EST Project”, Accession No. R96439, not filed, Oct. 1, 1995.
Hillier, L., et al., “Washu-NCI human EST Project”, Accession No. AA774984, not filed, Feb. 6, 1998.
Database Search, DNA sequence alignments [BLASTN 2.1.3 (Apr. 1, 2001), NCBI], A1-A4.
Database Search, protein sequence alignments [BLASTP 2.2.1 (Jul. 12, 2001), NCBI], B1-B2.
Bonnefoy et al.,Eur. Respir. J. Suppl. 22:63S-66S (1996).
Desnoyers Luc
Filvaroff Ellen
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Barnes Elizabeth M.
Dreger Ginger R.
Genentech Inc.
Kresnak Mark T.
Turner Sharon
LandOfFree
PRO792 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRO792 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO792 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798608